Humacyte Inc Warrant
HUMAW
12 hedge funds and large institutions have $2.04M invested in Humacyte Inc Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
8% less funds holding
Funds holding: 13 → 12 (-1)
17% less capital invested
Capital invested by funds: $2.45M → $2.04M (-$409K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$365K |
| 2 |
EAM
Exos Asset Management
New York
|
+$114K |
| 3 |
Jane Street
New York
|
+$255 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$379K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$139K |
| 3 |
GCL
Glazer Capital LLC
New York
|
-$133K |
| 4 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$113K |
| 5 |
Morgan Stanley
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
1
AQR Arbitrage
Greenwich,
Connecticut
| $420K | – | – | – |
|
|
ACM
2
Altium Capital Management
New York
| $385K | +$365K | +137,500 | New |
|
3
Balyasny Asset Management
Chicago,
Illinois
| $280K | – | – | – |
|
|
CH
4
CVI Holdings
Wilmington,
Delaware
| $193K | – | – | – |
|
|
EAM
5
Exos Asset Management
New York
| $163K | +$114K | +43,085 | +283% |
|
|
6
Jane Street
New York
| $142K | +$255 | +96 | +0.2% |
|
|
LP
7
LMR Partners
London,
United Kingdom
| $140K | – | – | – |
|
|
YCM
8
Yakira Capital Management
Westport,
Connecticut
| $110K | – | – | – |
|
|
CAC
9
Cowen and Company
New York
| $69K | -$379K | -142,862 | -85% |
|
|
PSAMP
10
P. Schoenfeld Asset Management (PSAM)
New York
| $54K | -$113K | -42,771 | -69% |
|
|
GCL
11
Glazer Capital LLC
New York
| $46K | -$133K | -50,193 | -75% |
|
12
Verition Fund Management
Greenwich,
Connecticut
| $42K | – | – | – |
|
|
MF
13
Magnetar Financial
Evanston,
Illinois
| – | -$139K | -46,500 | Closed |
|
|
14
Morgan Stanley
New York
| – | -$2K | -586 | Closed |
|
HUMAW Hedge Fund Activity: Q2 2021 in Review
12 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Humacyte Inc Warrant (HUMAW) for Q2 2021, worth a combined $2.04M — down 17% from $2.45M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of HUMAW and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $365K. The largest seller was Cowen and Company, cutting an estimated $379K.
- 12 institutional investors held Humacyte Inc Warrant (HUMAW) as of Q2 2021, down from 13 in Q1 2021.
- Funds reported $2.04M of Humacyte Inc Warrant stock for Q2 2021, down 17% quarter-over-quarter.
- 1 fund opened new Humacyte Inc Warrant positions in Q2 2021 and 2 closed out, a net change of -1 holder.
- The largest Humacyte Inc Warrant buyer in Q2 2021 was Altium Capital Management, an estimated $365K added.
- The largest Humacyte Inc Warrant seller in Q2 2021 was Cowen and Company, an estimated $379K sold.
Based on aggregated 13F filings for Q2 2021.